Skip to content

Aprea Therapeutics, Inc.

APRE

CIK 0001781983 · Pharmaceutical Preparations · Nasdaq

← back to feed
Revenue (TTM)
—
Q1 May 2026
Net Income (TTM)
−$13.43M
+2.8% YoY Q1 May 2026
EPS Diluted (TTM)
−$1.88
+17.9% YoY Q1 May 2026
Gross Margin
—
Q1 May 2026
Operating Margin
—
Q1 May 2026
Net Margin
—
Q1 May 2026
Free Cash Flow (TTM)
−$13.32M
Q1 May 2026
Cash
$46.47M
Q1 May 2026
Total Debt
—
Q1 May 2026
Shares Outstanding
12.38M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Cash Flow

Revenue Growth (YoY)

No data available for this metric.

Balance Sheet

Cash vs Debt

Recent filings